Indatuximab ravtansine (BT-062) treatment results in epithelial corneal damage and crystal inclusions as well as blurred vision and dry eye.18 The reversibility of the corneal and vision changes is not specified, but data from a phase 1/2 combination therapy study in multiple myeloma are expec...
holding, subsidiary, joint venture or associate companies of companies covered under sub-clause (a) of clause (iii) of sub-rule (1) and sub-clause (b) of clause (iii) of sub-rule (1), as the case may be:' It would be noted from the above that where a c...